
The European Union's invitation for market feedback on Sanofi's proposed antitrust commitments signals a potential resolution to a significant regulatory challenge, which could impact the company's operational freedom and competitive landscape in the pharmaceutical sector.
An AI breakdown of exactly what changed and who it moves.